Literature DB >> 23641946

Diaphragm dysfunction on admission to the intensive care unit. Prevalence, risk factors, and prognostic impact-a prospective study.

Alexandre Demoule1, Boris Jung, Hélène Prodanovic, Nicolas Molinari, Gerald Chanques, Catherine Coirault, Stefan Matecki, Alexandre Duguet, Thomas Similowski, Samir Jaber.   

Abstract

RATIONALE: Diaphragmatic insults occurring during intensive care unit (ICU) stays have become the focus of intense research. However, diaphragmatic abnormalities at the initial phase of critical illness remain poorly documented in humans.
OBJECTIVES: To determine the incidence, risk factors, and prognostic impact of diaphragmatic impairment on ICU admission.
METHODS: Prospective, 6-month, observational cohort study in two ICUs. Mechanically ventilated patients were studied within 24 hours after intubation (Day 1) and 48 hours later (Day 3). Seventeen anesthetized intubated control anesthesia patients were also studied. The diaphragm was assessed by twitch tracheal pressure in response to bilateral anterior magnetic phrenic nerve stimulation (Ptr,stim).
MEASUREMENTS AND MAIN RESULTS: Eighty-five consecutive patients aged 62 (54-75) (median [interquartile range]) were evaluated (medical admission, 79%; Simplified Acute Physiology Score II, 54 [44-68]). On Day 1, Ptr,stim was 8.2 (5.9-12.3) cm H2O and 64% of patients had Ptr,stim less than 11 cm H2O. Independent predictors of low Ptr,stim were sepsis (linear regression coefficient, -3.74; standard error, 1.16; P = 0.002) and Simplified Acute Physiology Score II (linear regression coefficient, -0.07; standard error, 1.69; P = 0.03). Compared with nonsurvivors, ICU survivors had higher Ptr,stim (9.7 [6.3-13.8] vs. 7.3 [5.5-9.7] cm H2O; P = 0.004). This was also true for hospital survivors versus nonsurvivors (9.7 [6.3-13.5] vs. 7.8 [5.5-10.1] cm H2O; P = 0.004). Day 1 and Day 3 Ptr,stim were similar.
CONCLUSIONS: A reduced capacity of the diaphragm to produce inspiratory pressure (diaphragm dysfunction) is frequent on ICU admission. It is associated with sepsis and disease severity, suggesting that it may represent another form of organ failure. It is associated with a poor prognosis. Clinical trial registered with www.clinicaltrials.gov (NCT 00786526).

Entities:  

Mesh:

Year:  2013        PMID: 23641946     DOI: 10.1164/rccm.201209-1668OC

Source DB:  PubMed          Journal:  Am J Respir Crit Care Med        ISSN: 1073-449X            Impact factor:   21.405


  115 in total

1.  How Important is Diaphragm Function as a Determinant of Outcomes for MICU Patients in Respiratory Failure?

Authors:  Gerald S Supinski; Leigh A Callahan
Journal:  Physiology (Bethesda)       Date:  2015-09

2.  Diaphragmatic dysfunction at admission in intensive care unit: the value of diaphragmatic ultrasonography.

Authors:  Xavier Valette; Amélie Seguin; Cédric Daubin; Jennifer Brunet; Bertrand Sauneuf; Nicolas Terzi; Damien du Cheyron
Journal:  Intensive Care Med       Date:  2015-01-20       Impact factor: 17.440

3.  Muscle dysfunction in patients with lung diseases: a growing epidemic.

Authors:  Esther Barreiro; Jacob I Sznajder; Gustavo A Nader; G R Scott Budinger
Journal:  Am J Respir Crit Care Med       Date:  2015-03-15       Impact factor: 21.405

4.  Measuring diaphragm thickness with ultrasound in mechanically ventilated patients: feasibility, reproducibility and validity.

Authors:  Ewan C Goligher; Franco Laghi; Michael E Detsky; Paulina Farias; Alistair Murray; Deborah Brace; Laurent J Brochard; Steffen-Sebastien Bolz; Steffen Sebastien-Bolz; Gordon D Rubenfeld; Brian P Kavanagh; Niall D Ferguson
Journal:  Intensive Care Med       Date:  2015-02-19       Impact factor: 17.440

5.  What's new in management and clearing of airway secretions in ICU patients? It is time to focus on cough augmentation.

Authors:  Nicolas Terzi; Claude Guerin; Miguel R Gonçalves
Journal:  Intensive Care Med       Date:  2018-12-05       Impact factor: 17.440

6.  Diaphragmatic ultrasound as a monitoring tool in the intensive care unit.

Authors:  Ioanna Sigala; Theodoros Vassilakopoulos
Journal:  Ann Transl Med       Date:  2017-02

7.  Diaphragm muscle fiber weakness and ubiquitin-proteasome activation in critically ill patients.

Authors:  Pleuni E Hooijman; Albertus Beishuizen; Christian C Witt; Monique C de Waard; Armand R J Girbes; Angelique M E Spoelstra-de Man; Hans W M Niessen; Emmy Manders; Hieronymus W H van Hees; Charissa E van den Brom; Vera Silderhuis; Michael W Lawlor; Siegfried Labeit; Ger J M Stienen; Koen J Hartemink; Marinus A Paul; Leo M A Heunks; Coen A C Ottenheijm
Journal:  Am J Respir Crit Care Med       Date:  2015-05-15       Impact factor: 21.405

8.  MitoTEMPOL, a mitochondrial targeted antioxidant, prevents sepsis-induced diaphragm dysfunction.

Authors:  Gerald S Supinski; Lin Wang; Elizabeth A Schroder; Leigh Ann P Callahan
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2020-05-27       Impact factor: 5.464

Review 9.  Assessment of diaphragmatic dysfunction in the critically ill patient with ultrasound: a systematic review.

Authors:  Massimo Zambon; Massimiliano Greco; Speranza Bocchino; Luca Cabrini; Paolo Federico Beccaria; Alberto Zangrillo
Journal:  Intensive Care Med       Date:  2016-09-12       Impact factor: 17.440

10.  Diaphragmatic dysfunction in patients with ICU-acquired weakness and its impact on extubation failure.

Authors:  Boris Jung; Pierre Henri Moury; Martin Mahul; Audrey de Jong; Fabrice Galia; Albert Prades; Pierre Albaladejo; Gerald Chanques; Nicolas Molinari; Samir Jaber
Journal:  Intensive Care Med       Date:  2015-11-16       Impact factor: 17.440

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.